Toshifumi Hibi
Centre for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University · Kitasato University Kitasato Institute Hospital · Department of Internal Medicine, Keio University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Toshifumi Hibi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:00 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01959165 · MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis PatientsAstraZeneca · completed · Ulcerative Colitis · principal investigator
- Ph3NCT01585155 · Clinical Study of TA-650 in Pediatric Patients With Ulcerative ColitisTanabe Pharma Corporation · completed · Pediatric Ulcerative Colitis · study director
- Ph3NCT01580670 · Clinical Study of TA-650 in Pediatric Patients With Crohn's DiseaseTanabe Pharma Corporation · completed · Pediatric Crohn's Disease · study director
- Ph3NCT01532570 · Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special LesionsTanabe Pharma Corporation · completed · Behcet's Disease, Behcet Syndrome, Neuro-Behcet's Disease · study director
- Ph3NCT01514240 · Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in JapanAstraZeneca · completed · Crohn's Disease · principal investigator
- Ph3NCT00805766 · Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)Tanabe Pharma Corporation · completed · Crohn's Disease · study chair
- Ph2NCT00417391 · Phase II Study of RR110 in Patients With Active Crohn's DiseaseR&R Inc. · completed · Crohn's Disease · study chair
- Ph4NCT00247130 · Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding UlcerKeio University · withdrawn · Peptic Ulcers · study chair
- Ph4NCT00219414 · Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)Otsuka Frankfurt Research Institute GmbH · completed · Ulcerative Colitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:00 UTC. The ranking covers the 200 most relevant of 97 PubMed records, and a shared surname and initials can bring in a namesake. All 97 on PubMed
- Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.Gastroenterology · 2014795 citationsRCR 27.9
- A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.Gastroenterology · 2004516 citationsRCR 10.6
- 400 citationsRCR 26.5
- A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.Gut · 2006357 citationsRCR 10.6
- 198 citationsRCR 5.6
- A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.Gastroenterology · 2008197 citationsRCR 5.9
- Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial.J Crohns Colitis · 2016197 citationsRCR 8.9
- Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.Gastroenterology · 2020195 citationsRCR 9.7
- Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.Gastroenterology · 2018184 citationsRCR 7.2
- Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis.Inflamm Bowel Dis · 2012175 citationsRCR 6.1